Published in Pituitary on January 01, 2005
Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol (2009) 2.23
The Treatment of Cushing's Disease. Endocr Rev (2015) 1.35
Central hypothyroidism. Indian J Endocrinol Metab (2011) 0.82
Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer. Lancet Diabetes Endocrinol (2015) 0.81
Pediatric brain tumor treatment: growth consequences and their management. Pediatr Endocrinol Rev (2010) 0.79
Pituitary insufficiency after operation of supratentorial intra- and extraaxial tumors outside of the sellar-parasellar region? Neurosurg Rev (2011) 0.78
Effect of treatment modality on the hypothalamic-pituitary function of patients treated with radiation therapy for pituitary adenomas: hypothalamic dose and endocrine outcomes. Front Oncol (2014) 0.77
The evaluation of function and the ultrasonographic picture of thyroid in children treated for medulloblastoma. Childs Nerv Syst (2011) 0.76
Pituitary hormone dysfunction after proton beam radiation therapy in children with brain tumors. Endocr Pract (2011) 0.76
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet (2004) 8.77
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2006) 1.73
Quality of life, self-esteem, fatigue, and sexual function in young men after cancer: a controlled cross-sectional study. Cancer (2010) 1.59
The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr Rev (2006) 1.24
Endocrine late effects after bone marrow transplant. Br J Haematol (2002) 1.17
HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. J Clin Endocrinol Metab (2006) 1.12
Do doctors discuss fertility issues before they treat young patients with cancer? Hum Reprod (2008) 1.10
Hypopituitarism following Radiotherapy Revisited. Endocr Dev (2009) 1.06
Hypopituitarism following radiotherapy. Pituitary (2009) 1.02
Molecular mechanisms of thyroid hormone effects on bone growth and function. Mol Genet Metab (2002) 0.95
Impact of growth hormone status on body composition and the skeleton. Horm Res (2004) 0.95
Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth. Pediatr Res (2002) 0.95
Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance. Am J Physiol Endocrinol Metab (2002) 0.93
Iodothyronine deiodinase enzyme activities in bone. Bone (2008) 0.91
Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors. Clin Endocrinol (Oxf) (2005) 0.91
Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. J Clin Endocrinol Metab (2003) 0.89
IGF-I, IGF binding protein-3 and breast cancer risk: comparison of 3 meta-analyses. Int J Cancer (2005) 0.89
The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index. Clin Endocrinol (Oxf) (2009) 0.89
Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal. J Clin Endocrinol Metab (2007) 0.88
Determination of IGF-I, IGF-II, IGFBP-2, and IGFBP-3 levels in serum and plasma: comparisons using the Bland-Altman method. Growth Horm IGF Res (2003) 0.88
Fertility preservation and management of gonadal failure associated with lymphoma therapy. Curr Oncol Rep (2002) 0.88
Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders. J Clin Endocrinol Metab (2003) 0.87
Adults with partial growth hormone deficiency have an adverse body composition. J Clin Endocrinol Metab (2004) 0.87
Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients. J Clin Endocrinol Metab (2004) 0.86
A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency. J Clin Endocrinol Metab (2005) 0.86
Hypothyroidism following childhood cancer therapy-an under diagnosed complication. Int J Cancer (2011) 0.84
Determinants of IGF-I status in a large cohort of growth hormone-deficient (GHD) subjects: the role of timing of onset of GHD. Clin Endocrinol (Oxf) (2003) 0.84
Acromegaly and colorectal cancer: risk assessment should be based on population-based studies. J Clin Endocrinol Metab (2002) 0.84
Treatment of acromegaly improves quality of life, measured by AcroQol. Clin Endocrinol (Oxf) (2007) 0.84
Lipid profiles in untreated severe congenital isolated growth hormone deficiency through the lifespan. Clin Endocrinol (Oxf) (2002) 0.84
Absence of adrenocorticotropin (ACTH) neurosecretory dysfunction but increased cortisol concentrations and production rates in ACTH-replete adult cancer survivors after cranial irradiation for nonpituitary brain tumors. J Clin Endocrinol Metab (2005) 0.84
Growth hormone replacement throughout life: insights into age-related responses to treatment. Growth Horm IGF Res (2007) 0.84
Circadian secretion pattern of copeptin, the C-terminal vasopressin precursor fragment. Clin Chem (2010) 0.84
Diabetes, insulin therapy, and colorectal cancer. BMJ (2005) 0.83
Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. J Clin Endocrinol Metab (2002) 0.83
Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individuals. Circulation (2004) 0.82
Ultrastructural preservation of ovarian cortical tissue cryopreserved in dimethylsulfoxide for subsequent transplantation into young female cancer patients. Ultrastruct Pathol (2005) 0.82
Differential effects of GH replacement on the components of the leptin system in GH-deficient individuals. J Clin Endocrinol Metab (2002) 0.82
Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement. Growth Horm IGF Res (2006) 0.82
GH responsiveness varies during the menstrual cycle. Eur J Endocrinol (2005) 0.82
The insulin-like growth factor-I generation test: peripheral responsiveness to growth hormone is not decreased with ageing. Clin Endocrinol (Oxf) (2003) 0.81
Quality of life in childhood onset growth hormone-deficient patients in the transition phase from childhood to adulthood. J Clin Endocrinol Metab (2005) 0.81
GH replacement reduces increased lipid peroxidation in GH-deficient adults. Clin Endocrinol (Oxf) (2007) 0.81
Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J Clin Endocrinol Metab (2003) 0.81
The impact of dose and route of estrogen administration on the somatotropic axis in normal women. J Clin Endocrinol Metab (2003) 0.81
Partial growth hormone deficiency is associated with an adverse cardiovascular risk profile and increased carotid intima-medial thickness. Clin Endocrinol (Oxf) (2010) 0.80
Insulin sensitivity is impaired in adults with varying degrees of GH deficiency. Clin Endocrinol (Oxf) (2005) 0.80
Bone mineral density in childhood survivors of acute lymphoblastic leukemia treated without cranial irradiation. J Clin Endocrinol Metab (2004) 0.80
Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer. Best Pract Res Clin Endocrinol Metab (2002) 0.80
Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity. J Clin Endocrinol Metab (2004) 0.80
Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. Eur J Endocrinol (2009) 0.80
Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy. J Clin Endocrinol Metab (2004) 0.79
Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors. J Clin Endocrinol Metab (2005) 0.79
A new missense mutation in the growth hormone-releasing hormone receptor gene in familial isolated GH deficiency. Eur J Endocrinol (2003) 0.79
The impact of short-term fasting on the dynamics of 24-hour growth hormone (GH) secretion in patients with severe radiation-induced GH deficiency. J Clin Endocrinol Metab (2005) 0.79
Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis. Clin Endocrinol (Oxf) (2003) 0.78
The diagnosis of partial growth hormone deficiency in adults with a putative insult to the hypothalamo-pituitary axis. J Clin Endocrinol Metab (2007) 0.78
A new sustained-release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile. Clin Endocrinol (Oxf) (2005) 0.78
Growth hormone and the transition from puberty into adulthood. Endocrinol Metab Clin North Am (2007) 0.78
Prospects for the development of long-acting formulations of human somatropin. Treat Endocrinol (2006) 0.77
Interdependence of lean body mass and total body water, but not quality of life measures, during low dose GH replacement in GH-deficient adults. Eur J Endocrinol (2005) 0.77
A novel MEN1 intronic mutation associated with multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) (2007) 0.77
The dynamics of growth hormone (GH) secretion in adult cancer survivors with severe GH deficiency acquired after brain irradiation in childhood for nonpituitary brain tumors: evidence for preserved pulsatility and diurnal variation with increased secretory disorderliness. J Clin Endocrinol Metab (2005) 0.77
Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency). Clin Endocrinol (Oxf) (2008) 0.77
Confirmation of severe GH deficiency after final height in patients diagnosed as GH deficient during childhood. Clin Endocrinol (Oxf) (2002) 0.77
Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly. J Clin Endocrinol Metab (2004) 0.76
Plasma total homocysteine concentrations in adults with growth hormone (GH) deficiency: effects of GH replacement. Mol Genet Metab (2003) 0.76
Childhood-onset growth hormone (GH) deficiency in adult life. Best Pract Res Clin Endocrinol Metab (2002) 0.76
A new X-linked mental retardation (XLMR) syndrome with late-onset primary testicular failure, short stature and microcephaly maps to Xq25-q26. Eur J Med Genet (2007) 0.76
Effect of aromatizable and unaromatizable androgen replacement in hypogonadal men on GH responsiveness. Clin Endocrinol (Oxf) (2008) 0.75
Skeletal requirements for optimal growth hormone replacement in the transitional years. Growth Horm IGF Res (2003) 0.75
Critical illness as a model of hypothalamic ageing. Novartis Found Symp (2002) 0.75
GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset. Clin Endocrinol (Oxf) (2009) 0.75
The effects of sex steroid replacement therapy on an expanded panel of IGF-related peptides. Growth Horm IGF Res (2007) 0.75
The insulin-like growth factor I generation test in adults. Horm Res (2004) 0.75
Difficulties in patient management associated with the transition period. Horm Res (2005) 0.75
Growth hormone replacement therapy (GHRT) in children and adolescents: skeletal impact. Med Pediatr Oncol (2003) 0.75
Determination of large bowel length and loop complexity in patients with acromegaly undergoing screening colonoscopy. Clin Endocrinol (Oxf) (2005) 0.75
Serum vascular endothelial growth factor (VEGF) is elevated in GH deficient adults. Growth Horm IGF Res (2011) 0.75